CLINICAL_TRIALS
trial_result
· 2013-06-18
Clinical Trial Update: Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer [Phase 2]
Summary
A Phase 2 trial evaluating cetuximab in combination with chemotherapy for stage IV colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED